[1]Fasolato S, Angeli P, Dallagnese L, et al.:Renal failure and bac-terial infections in patients with cirrhosis:epidemiology and clinicalfeatures[J].Hepatology, 2007, 45 (1) ∶223-229.
|
[2]Helvig FC, Schutz CB. A liver and kidney syndrome: clinical, pathological, and experimental studies[J]. Surg Gynecol Obstet, 1932, 55 (4) ∶570-582.
|
[3]Gines P, Guevara M, Arroyo V, et al. Hepato-renal syndrome[J]. Lancet, 2003, 362 (9398) ∶1819-1827.
|
[4]Vicente Arroyo, Carlos Terra, Pere Gine`s.Advances in the patho-genesis and treatment of type-1 and type-2 hepatorenalsyndrome[J].Journal of Hepatology, 2007, 46 (5) ∶935-946.
|
[5]Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score[J]. Gastroenterology, 2005, 129 (6) ∶1944-1953.
|
[6]Fasolato S, Angeli P, Dallagnese, L, et al.Renal failure and bac-terial infections in patients with cirrhosis:epidemiology and clinicalfeatures[J].Hepatology, 2007, 45 (1) ∶223-229.
|
[7]Fernandez J, Monteagudo J, Bargallo X, et al.A randomized un-blinded pilot study comparing albumin versus hydroxyethyl starch inspontaneous bacterial peritonitis[J].Hepatology, 2005, 42 (43) ∶627-634.
|
[8]Moore K, Wong F, Gines P, et al.The management of ascites incirrhosis:report on the consensus conference of the international as-cites club[J].Hepatology, 2003, 38 (1) ∶258-266.
|
[9]Gines A, Escorsell A, Gines P, et al.Incidence, predictive factorsand prognosis of the hepato-renal syndrome in cirrhosis with asci-tes[J].Gastroenterology, 1993, 105 (1) ∶229-236.
|
[10]Hennenberg M, Trebicka J, Sauerbruch T, et al. Mechanisms of extrahepatic vasodilation in portal Hypertension[J].Gut, 2008, 57 (9) ∶1300-1314.
|
[11]Sieber CC, Lopeztalavera JC, Groszmann RJ. Role of nitric-oxide in the invitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats[J]. Gastroenterology, 1993, 104 (6) ∶1750-1754.
|
[12]Coll M, GenescàJ, Raurell I, et al.Genetic down-regulation ofgenes related to the adrenergic system might have a role in splanch-nic vasodilation of portal hypertension[J].Journal of Hepatology, 2008, 49 (1) ∶43-51.
|
[13]Geerts AM, De Vriese AS, Vanheule E, et al.Increased angiogen-esis and permeability in the mesenteric microvasculature of rats withcirrhosis and portal hypertension:an in vivo study[J].Liver Int, 2006, 26 (7) ∶889-898.
|
[14]Ruiz-del-Arbol W, Urman J, Fernandez J, et al.Systemic, re-nal, and hepatic hemodynamic derangement in cirrhotic patientswith spontaneous bacterial peritonitis[J].Hepatology, 2003, 38 (5) ∶1210-1218.
|
[15]Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrom cirrhosis[J]. Hepatology, 2005, 42 (2) ∶439-447.
|
[16]Ma ZH, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter[J]. Hepatology, 1996, 24 (2) ∶451-459.
|
[17]Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis[J]. Journal of Hepatology, 2008, 48 (suppl 1) ∶ S93-S103.
|
[18]Arroyo V, Colmenero J.Ascites and hepatorenal syndrome in cir-rhosis:pathophysiological basis of therapy and currentmanagement[J].J Hepatol, 2003, 38 (suppl 1) ∶S69-S89.
|
[19]Wadei HM, Mai ML, Ahsan N, et al.Hepatorenalsyndrome:Patho-physiology and management[J].Clin J AmSoeNePhrol, 2006, 1 (5) ∶1066-1079.
|
[20]Stadlbauer V, Wright GAK, Banaji M, et al. Relationship between activation of the sympathetic nervous system and renal blood flow auto regulation in cirrhosis[J]. Gastroenterology, 2008, 134 (1) ∶111-119.
|
[21]Papadakis MA, Arieff AI. Unpredictability of clinical-evaluation of renal-function in cirrhosis prospective-study[J]. Am J Med, 1987, 82 (5) ∶945-952.
|
[22]Caregaro L, Menon F, Angeli P, Amodio P, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis[J]. Arch Intern Med, 1994, 154 (2) ∶201-205.
|
[23]Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls[J]. Am J Kidney Dis, 2003, 41 (2) ∶269-278.
|
[24]Gtzberger M., Kaiser C, Landauer N, et al.Intrarenal resistanceindex for the assessment of early renal function impairment in pa-tients with liver cirrhosis[J].European Journal of Medical Re-search, 2008, 13 (8) ∶383-387.
|
[1] | XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing. Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2478-2483. doi: 10.3969/j.issn.1001-5256.2020.11.016 |
[2] | Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045 |
[3] | Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443. |
[4] | Zhao ZhengBin, Li JunFeng, Huang ShuangSheng, Zhang LiTing, Chen Hong. The advances of profibrogenic research of leptin and its signaling pathways in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1106-1108. |
[6] | Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196. |
[7] | Li Mei, Liang YingYin, Lin HongZheng, Xu Ya, Chen SongLin, Liu SiChun. Clinical analysis of 32 cases with alcoholic liver disease and alcohol with drawal syndrome[J]. Journal of Clinical Hepatology, 2007, 23(1): 38-39. |
[8] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[9] | Li RuiYan, Xiong JinHu. Evaluation of the clinical value of the concentration of leptin in viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 96-97. |
[11] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[12] | Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196. |
[13] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[14] | Wang RuiKe, Liu XiuZhen, Zhang GuYun, Li Hong, Sun ZhaoCui, Zhang JinAn. Monitoring the change of interleukin-6 in the alcoholic liver disease and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(2): 100-101. |
[15] | Wang HaiQin, Li JuanJuan. Therapeutic effect of GSH on the treatment of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(6): 355-356. |
[16] | Li ChuanFeng, Huang YongCan, Qiu Xiang, Po YunFeng. Clinical analysis of 146 cases of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(3): 157-158. |
[17] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin, Liu RongHua. The relationship between serum leptin levels and the levels of fibrosis marks in patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 85-86. |